
Sign up to save your podcasts
Or
Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate.
Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids.
Emily Willingham will also be speaking at the upcoming Women in Secularism conference, September 23-25 in Arlington, VA. For more information go to womeninsecularism.org.
Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate.
Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids.
Emily Willingham will also be speaking at the upcoming Women in Secularism conference, September 23-25 in Arlington, VA. For more information go to womeninsecularism.org.
938 Listeners
2,372 Listeners
2,655 Listeners
430 Listeners
705 Listeners
2,833 Listeners
4,039 Listeners
954 Listeners
825 Listeners
959 Listeners
1,395 Listeners
191 Listeners
914 Listeners
4,136 Listeners
488 Listeners